MenHibrix receives complete response

FDA issued a complete response letter for a BLA from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for MenHibrix vaccine against Neisseria meningitidis serogroups C and Y, and Haemophilus influenzae type ...